VCNX - バクシネックス (Vaccinex Inc.)

VCNXのニュース

   The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac  2020/09/30 11:45:51 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc (NASDAQ: XLRN ) (announced Health Canada approval of luspatercept for RBC transfusion-dependent anemia associated with beta-thalassemia) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Adial Pharmaceuticals Inc (NASDAQ: ADIL )(announced EUA for antibody test for COVID-19) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Fate Therapeutics Inc (NASDAQ: FATE ) Guardant Health Inc (NASDAQ: GH ) Inspire Medical Systems Inc (NYSE: INSP ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO )(announced dosing of first patient in ulcerative colitis study) Kura Oncology Inc (NASDAQ: KURA ) Lantern Pharma Inc.
   The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates  2020/09/26 18:40:57 Benzinga
Biotech stock reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson (NYSE: JNJ ) kickstarting a Phase 3 trial of its coronavirus vaccine candidate. A few clinical readouts released during the week triggered strong moves. Vaccinex Inc (NASDAQ: VCNX ) and AC Immune SA (NASDAQ: ACIU ) were among the worst decliners of the week, with the former reacting to a failed mid-stage trial of lead drug in Huntington's disease, while the latter plunged after an out-licensed Alzheimer's drug flunked a mid-stage trial. Here are the key catalysts for the unfolding week. Conferences World Muscle Society, or WMS, 25: Virtual Congress: Sept. 28-Oct. 2 Annual Northeast Amyotrophic Lateral Sclerosis, or NEALS, meeting: Sept. 30- Oct. 1 Heart Failure Society of America, or HFSA, Virtual Annual Scientific Meeting 2020: Sept. 30-Oct. 6 virtual Jefferies Cell Therapy Summit: Oct. 5-6 Virtual Jefferies Gene Therapy/Editing Summit: Oct. 1-2 North American Neuroendocrine Tumor Society, or NANETS', Multidisciplinary NET Medical Virtual Symposium: Oct.
   Vaccinex Plummets After Lead Drug Flunks Midstage Huntingon's Disease Study  2020/09/22 11:20:00 Benzinga
Shares of micro-cap immunotherapy company Vaccinex Inc (NASDAQ: VCNX) were plunging Tuesday in reaction to an adverse readout. What Happened: Top-line …
   Thinking about buying stock in Barnes & Noble Education, Vaccinex Inc, Seelos Therapeutics, PDS Biotechnology, or SINTX Technologies?  2020/07/17 13:31:00 PR Newswire
NEW YORK, July 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNED, VCNX, SEEL, PDSB, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates  2020/05/14 14:05:02 Zacks Investment Research
Vaccinex Inc (VCNX) delivered earnings and revenue surprises of 8.16% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac  2020/09/30 11:45:51 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc (NASDAQ: XLRN ) (announced Health Canada approval of luspatercept for RBC transfusion-dependent anemia associated with beta-thalassemia) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Adial Pharmaceuticals Inc (NASDAQ: ADIL )(announced EUA for antibody test for COVID-19) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Fate Therapeutics Inc (NASDAQ: FATE ) Guardant Health Inc (NASDAQ: GH ) Inspire Medical Systems Inc (NYSE: INSP ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO )(announced dosing of first patient in ulcerative colitis study) Kura Oncology Inc (NASDAQ: KURA ) Lantern Pharma Inc.
   The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates  2020/09/26 18:40:57 Benzinga
Biotech stock reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson (NYSE: JNJ ) kickstarting a Phase 3 trial of its coronavirus vaccine candidate. A few clinical readouts released during the week triggered strong moves. Vaccinex Inc (NASDAQ: VCNX ) and AC Immune SA (NASDAQ: ACIU ) were among the worst decliners of the week, with the former reacting to a failed mid-stage trial of lead drug in Huntington's disease, while the latter plunged after an out-licensed Alzheimer's drug flunked a mid-stage trial. Here are the key catalysts for the unfolding week. Conferences World Muscle Society, or WMS, 25: Virtual Congress: Sept. 28-Oct. 2 Annual Northeast Amyotrophic Lateral Sclerosis, or NEALS, meeting: Sept. 30- Oct. 1 Heart Failure Society of America, or HFSA, Virtual Annual Scientific Meeting 2020: Sept. 30-Oct. 6 virtual Jefferies Cell Therapy Summit: Oct. 5-6 Virtual Jefferies Gene Therapy/Editing Summit: Oct. 1-2 North American Neuroendocrine Tumor Society, or NANETS', Multidisciplinary NET Medical Virtual Symposium: Oct.
   Vaccinex Plummets After Lead Drug Flunks Midstage Huntingon's Disease Study  2020/09/22 11:20:00 Benzinga
Shares of micro-cap immunotherapy company Vaccinex Inc (NASDAQ: VCNX) were plunging Tuesday in reaction to an adverse readout. What Happened: Top-line …
   Thinking about buying stock in Barnes & Noble Education, Vaccinex Inc, Seelos Therapeutics, PDS Biotechnology, or SINTX Technologies?  2020/07/17 13:31:00 PR Newswire
NEW YORK, July 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNED, VCNX, SEEL, PDSB, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates  2020/05/14 14:05:02 Zacks Investment Research
Vaccinex Inc (VCNX) delivered earnings and revenue surprises of 8.16% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Thinking about buying stock in Barnes & Noble Education, Vaccinex Inc, Seelos Therapeutics, PDS Biotechnology, or SINTX Technologies?  2020/07/17 13:31:00 PR Newswire
NEW YORK, July 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNED, VCNX, SEEL, PDSB, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Vaccinex Inc (VCNX) Reports Q1 Loss, Lags Revenue Estimates  2020/05/14 14:05:02 Zacks Investment Research
Vaccinex Inc (VCNX) delivered earnings and revenue surprises of 8.16% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   Vaccinex Inc (VCNX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release  2020/05/13 16:30:22 Zacks Investment Research
Vaccinex Inc (VCNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO  2020/05/01 11:54:30 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 1.) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) AstraZeneca plc (NYSE: AZN ) (announced an agreement with the University of Oxford for the development of the latter's potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2) BIO-TECHNE Corp (NASDAQ: TECH ) (reacted to its quarterly results) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Catalent Inc (NYSE: CTLT ) ChemoCentryx Inc (NASDAQ: CCXI ) DexCom, Inc. (NASDAQ: DXCM ) Imara Inc (NASDAQ: IMRA ) Replimune Group Inc (NASDAQ: REPL ) Down In The Dumps (Biotech stocks that hit 52-week lows May 1.) Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) Vaccinex Inc (NASDAQ: VCNX ) Stocks In Focus Bio-Rad's Serology Test Gets EUA From FDA For Novel Coronavirus Test Bio-Rad said the FDA granted Emergency Use Authorization for its SARS-CoV-2 Total Ab test, making it the first total antibody test to receive EUA from the FDA.
   The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant  2020/04/16 12:09:13 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) C alithera Biosciences Inc (NASDAQ: CALA ) (provided an update on the impact of COVID-19 on its ongoing clinical trials) Eli Lilly And Co (NYSE: LLY ) Keros Therapeutics Inc (NASDAQ: KROS ) (went public April 8) Masimo Corporation (NASDAQ: MASI ) Moderna Inc (NASDAQ: MRNA (analysts hiked price targets for the shares following the company's Virtual Vaccines Day) Pluristem Therapeutics Inc. (NASDAQ: PSTI ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows April 15.) Akorn, Inc. (NASDAQ: AKRX ) AxoGen, Inc Common Stock (NASDAQ: AXGN ) TherapeuticsMD Inc (NASDAQ: TXMD ) Vaccinex Inc (NASDAQ: VCNX ) Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter .

calendar